Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Ejhaem|January 27, 2025
What is the origin of the normal ranges of blood cell counts? An evolutionary perspectiveManon Zala, Vincent Alcazer, Laetitia Largeaud, et al.
Expert Review of Hematology|April 29, 2023
VEXAS: is it time to reshape the nosology of clonal hematopoiesis?Pierre Sujobert, Laetitia Largeaud, Yvan Jamilloux, et al.
Biomarker Research|December 10, 2020
Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapseSarah Cadot, Carine Valle, Marie Tosolini, et al.
Plos Medicine|July 22, 2024
New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modelingSarah Cadot, Chloe Audebert, Charlotte Dion, et al.
European Journal of Haematology|May 27, 2020
Dactinomycin in acute myeloid leukemia with NPM1 mutationsGuillaume Beziat, Suzanne Tavitian, Sarah Bertoli, et al.
The FEBS Journal|September 26, 2024
The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemiaJaja Zhu, Hippolyte Guérineau, Anne-Margaux Lefebvre-Fortané, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Leukemia Research|May 6, 2019
Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitorsLaetitia Largeaud, Emilie Bérard, Sarah Bertoli, et al.
Cancers|May 10, 2020
CD34<sup>+</sup>CD38<sup>-</sup>CD123<sup>+</sup> Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating AgentsFrançois Vergez, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.
Blood Advances|September 6, 2023
Vitamin C and D supplementation in acute myeloid leukemiaPierre Luc Mouchel, Emilie Bérard, Suzanne Tavitian, et al.
Pageof 4